POOCHON SCIENTIFIC LLC

Poochon Scientific LLC specializes in advanced molecular and proteomic laboratory services, delivering high-precision sequencing, oligonucleotide synthesis, and mass spectrometry-based proteomic profiling to support cutting-edge biomedical research. Their core capabilities include Sanger and next-generation sequencing for molecular cloning, CRISPR/Cas9 genome editing validation, and whole plasmid characterization, alongside liquid chromatography-tandem mass spectrometry (LC/MS/MS) for protein identification and proteomic analysis of complex biological samples such as brain organoids. The firm demonstrates deep expertise in translational research workflows, enabling precise characterization of nucleic acid and protein targets critical to therapeutic development and functional genomics. Their technical differentiation lies in end-to-end support for high-complexity, low-volume research workflows requiring stringent data integrity and rapid turnaround, particularly in academic and government-funded life sciences environments. The company maintains a consistent relationship with the Department of Health and Human Services, providing specialized laboratory services to research laboratories engaged in molecular biology, gene therapy, and neurobiological studies. Their work supports federally funded investigations into gene editing outcomes, antisense oligonucleotide (ASO) mechanisms, and genomic stability, indicating a trusted role in sustaining critical research continuity across multiple HHS sub-agencies. Poochon Scientific operates primarily under NAICS 541380, focusing on testing laboratories and services for life sciences research. They are positioned as a niche provider for specialized, non-routine analytical services that require advanced instrumentation and domain-specific expertise, serving the biodefense, neuropharmacology, and gene therapy segments within the federal research ecosystem. As a small business structured as 2K and based in Frederick, Maryland, Poochon Scientific leverages its proximity to federal research hubs to deliver responsive, high-quality laboratory support. While currently holding no formal government certifications, their demonstrated technical proficiency and consistent performance with HHS labs establish a credible footprint in the federal life sciences contracting market.